Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease

Resveratrol (RSV) is a phenolic compound with strong antioxidant activity, which is generally associated with the beneficial effects of wine on human health. All resveratrol-mediated benefits exerted on different systems and pathophysiological conditions are possible through resveratrol’s interactio...

Full description

Bibliographic Details
Main Authors: Melania Gaggini, Simona Fenizia, Cristina Vassalle
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/12/5/1102
_version_ 1797601302828548096
author Melania Gaggini
Simona Fenizia
Cristina Vassalle
author_facet Melania Gaggini
Simona Fenizia
Cristina Vassalle
author_sort Melania Gaggini
collection DOAJ
description Resveratrol (RSV) is a phenolic compound with strong antioxidant activity, which is generally associated with the beneficial effects of wine on human health. All resveratrol-mediated benefits exerted on different systems and pathophysiological conditions are possible through resveratrol’s interactions with different biological targets, along with its involvement in several key cellular pathways affecting cardiometabolic (CM) health. With regard to its role in oxidative stress, RSV exerts its antioxidant activity not only as a free radical scavenger but also by increasing the activity of antioxidant enzymes and regulating redox genes, nitric oxide bioavailability and mitochondrial function. Moreover, several studies have demonstrated that some RSV effects are mediated by changes in sphingolipids, a class of biolipids involved in a number of cellular functions (e.g., apoptosis, cell proliferation, oxidative stress and inflammation) that have attracted interest as emerging critical determinants of CM risk and disease. Accordingly, this review aimed to discuss the available data regarding the effects of RSV on sphingolipid metabolism and signaling in CM risk and disease, focusing on oxidative stress/inflammatory-related aspects, and the clinical implications of this relationship.
first_indexed 2024-03-11T03:59:15Z
format Article
id doaj.art-078610ac202347ac84a2935fbbafc170
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-11T03:59:15Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-078610ac202347ac84a2935fbbafc1702023-11-18T00:15:38ZengMDPI AGAntioxidants2076-39212023-05-01125110210.3390/antiox12051102Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and DiseaseMelania Gaggini0Simona Fenizia1Cristina Vassalle2Institute of Clinical Physiology, National Research Council of Italy (CNR), Via Moruzzi 1, I-56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council of Italy (CNR), Via Moruzzi 1, I-56124 Pisa, ItalyFondazione G. Monasterio CNR-Regione Toscana, Via Moruzzi 1, I-56124 Pisa, ItalyResveratrol (RSV) is a phenolic compound with strong antioxidant activity, which is generally associated with the beneficial effects of wine on human health. All resveratrol-mediated benefits exerted on different systems and pathophysiological conditions are possible through resveratrol’s interactions with different biological targets, along with its involvement in several key cellular pathways affecting cardiometabolic (CM) health. With regard to its role in oxidative stress, RSV exerts its antioxidant activity not only as a free radical scavenger but also by increasing the activity of antioxidant enzymes and regulating redox genes, nitric oxide bioavailability and mitochondrial function. Moreover, several studies have demonstrated that some RSV effects are mediated by changes in sphingolipids, a class of biolipids involved in a number of cellular functions (e.g., apoptosis, cell proliferation, oxidative stress and inflammation) that have attracted interest as emerging critical determinants of CM risk and disease. Accordingly, this review aimed to discuss the available data regarding the effects of RSV on sphingolipid metabolism and signaling in CM risk and disease, focusing on oxidative stress/inflammatory-related aspects, and the clinical implications of this relationship.https://www.mdpi.com/2076-3921/12/5/1102resveratrolsphingolipidsceramidessphingosine-1-phosphatecardiometabolic riskcardiometabolic disease
spellingShingle Melania Gaggini
Simona Fenizia
Cristina Vassalle
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
Antioxidants
resveratrol
sphingolipids
ceramides
sphingosine-1-phosphate
cardiometabolic risk
cardiometabolic disease
title Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
title_full Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
title_fullStr Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
title_full_unstemmed Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
title_short Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
title_sort sphingolipid levels and signaling via resveratrol and antioxidant actions in cardiometabolic risk and disease
topic resveratrol
sphingolipids
ceramides
sphingosine-1-phosphate
cardiometabolic risk
cardiometabolic disease
url https://www.mdpi.com/2076-3921/12/5/1102
work_keys_str_mv AT melaniagaggini sphingolipidlevelsandsignalingviaresveratrolandantioxidantactionsincardiometabolicriskanddisease
AT simonafenizia sphingolipidlevelsandsignalingviaresveratrolandantioxidantactionsincardiometabolicriskanddisease
AT cristinavassalle sphingolipidlevelsandsignalingviaresveratrolandantioxidantactionsincardiometabolicriskanddisease